JAMA Netw Open. 2021 Jul 01;4(7):e2115859. doi: 10.1001/jamanetworkopen.2021.15859.
Disability-Adjusted Life-Years Associated With Intracerebral Hemorrhage and Secondary Injury.
JAMA network open
David Haupenthal, Joji B Kuramatsu, Bastian Volbers, Jochen A Sembill, Anne Mrochen, Stefanie Balk, Philip Hoelter, Hannes Lücking, Tobias Engelhorn, Arnd Dörfler, Stefan Schwab, Hagen B Huttner, Maximilian I Sprügel
Affiliations
Affiliations
- Department of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
PMID: 34279649
PMCID: PMC8290300 DOI: 10.1001/jamanetworkopen.2021.15859
Abstract
IMPORTANCE: Intracerebral hemorrhage (ICH) contributes significantly to the global burden of disease.
OBJECTIVE: To examine the association of ICH and secondary injury with disability-adjusted life-years (DALYs) for the individual patient.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted using data from the Universitätsklinikum Erlangen Cohort of Patients With Spontaneous Intracerebral Hemorrhage study. Consecutive patients admitted to a single tertiary care center from January 1, 2006, to December 31, 2015, were included. The sample comprised patients with oral anticoagulation-associated ICH (OAC-ICH) or primary spontaneous ICH (non-OAC-ICH). Statistical analysis was conducted from October 1 to December 31, 2020.
EXPOSURES: ICH occurrence and secondary injury.
MAIN OUTCOMES AND MEASURES: DALYs, years of life lost (YLL), and years lived with disability (YLD) were analyzed by hematoma location, ICH volume, and secondary injury (ie, hematoma expansion [HE], intraventricular hemorrhage [IVH], and perihemorrhagic edema [PHE]).
RESULTS: Among 1322 patients with ICH, 615 (46.5%) were women and the mean (SD) age at hospital admission was 71 (13) years; ICH was associated with a mean (SD) of 9.46 (8.08) DALYs, 5.72 (8.29) YLL, and 3.74 (5.95) YLD. There were statistically significant differences in mean (SD) DALYs by extent of hematoma volume (< 10 mL ICH: 7.05 [6.79] DALYs; 10-30 mL ICH: 9.91 [8.35] DALYs; >30 mL ICH: 12.42 [8.47] DALYs; P < .001) and ICH location (deep location: 10.60 [8.35] DALYs; lobar location: 8.18 [7.63] DALYs; cerebellum: 8.14 [6.80] DALYs; brainstem: 12.63 [9.21] DALYs; P < .001). Regarding population-level disease burden of secondary injuries after ICH, there was a statistically significant difference in mean (SD) by injury type, with 0.94 (3.19) DALYs for HE, 2.45 (4.16) DALYs for IVH, and 1.96 (2.66) DALYs for PHE (P < .001) among the entire ICH cohort. Regarding individual-level exposure to secondary injuries after ICH, there were a mean (SD) 7.14 (6.62) DALYs for HE, 4.58 (4.75) DALYs for IVH, and 3.35 (3.28) DALYs for PHE among patients with ICH affected by secondary injuries.
CONCLUSIONS AND RELEVANCE: These findings suggest that there is a high burden of disability associated with ICH and secondary injuries, and the findings may guide public health strategies. The study findings further suggest that IVH and PHE may be relevant for the overall outcome of patients with ICH, that DALYs may represent a viable outcome parameter for studies to evaluate treatment outcomes in ICH research, and that IVH and PHE may represent potential treatment targets.
References
- Lancet. 2017 Feb 11;389(10069):603-611 - PubMed
- Stroke. 2012 Apr;43(4):1163-70 - PubMed
- Lancet Neurol. 2020 Dec;19(12):1023-1032 - PubMed
- Stroke. 2019 Nov;50(11):3246-3254 - PubMed
- Stroke. 2010 Mar;41(3):471-7 - PubMed
- Stat Med. 1992 Dec;11(16):2083-91 - PubMed
- Stroke. 2019 Apr;50(4):995-998 - PubMed
- Neurology. 2018 Mar 20;90(12):e1005-e1012 - PubMed
- Cerebrovasc Dis. 2008;26(4):381-7 - PubMed
- N Engl J Med. 2016 Sep 15;375(11):1033-43 - PubMed
- Lancet. 2018 May 26;391(10135):2107-2115 - PubMed
- Lancet Neurol. 2019 May;18(5):428-438 - PubMed
- Stroke. 2021 Mar;52(3):975-984 - PubMed
- BMJ. 2006 May 6;332(7549):1080 - PubMed
- Stroke. 2014 Aug;45(8):2451-3 - PubMed
- Stroke. 2009 Dec;40(12):3828-33 - PubMed
- Br J Prev Soc Med. 1971 Nov;25(4):242-4 - PubMed
- Cerebrovasc Dis. 2017;44(1-2):26-34 - PubMed
- N Engl J Med. 2008 May 15;358(20):2127-37 - PubMed
- Stroke. 2006 Feb;37(2):404-8 - PubMed
- Neurology. 2019 Sep 17;93(12):e1159-e1170 - PubMed
- Radiology. 1982 Apr;143(1):91-6 - PubMed
- Ann Neurol. 2017 Jan;81(1):93-103 - PubMed
- J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104802 - PubMed
- Stat Methods Med Res. 2001 Jun;10(3):195-216 - PubMed
- Am J Public Health. 1982 Dec;72(12):1336-44 - PubMed
- Lancet. 2020 Jul 11;396(10244):129-142 - PubMed
- Lancet Glob Health. 2013 Nov;1(5):e259-81 - PubMed
- Neurology. 2019 Apr 9;92(15):e1688-e1697 - PubMed
- Lancet. 2012 Dec 15;380(9859):2197-223 - PubMed
- Stroke. 1996 Aug;27(8):1304-5 - PubMed
- Stroke. 2019 Aug;50(8):2016-2022 - PubMed
- Eur J Neurol. 2011 Nov;18(11):1323-8 - PubMed
- J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):783-791 - PubMed
- Lancet Neurol. 2019 May;18(5):439-458 - PubMed
- JAMA. 2015 Feb 24;313(8):824-36 - PubMed
- Ann Neurol. 2019 Oct;86(4):480-492 - PubMed
- Lancet. 2020 Oct 17;396(10258):1204-1222 - PubMed
- Lancet. 2019 Mar 9;393(10175):1021-1032 - PubMed
Publication Types